The DOI matches its Crossref record; 473 of the 473 references it cites were found in a registry or an index.
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Abstract
WHAT’S NEW SINCE THE 2010 GUIDELINES? Inclusion of guidance for the diagnosis and management of cholangiocarcinoma (CCA) in patients with and without primary sclerosing cholangitis (PSC) (Figures 5, 8, and 9). Introduction of the term relevant stricture, defined as any biliary stricture of the common hepatic duct or hepatic ducts associated with signs or symptoms of obstructive cholestasis and/or bacterial cholangitis (Table 1). In patients with equivocal MRI with cholangiopancreatography (MRI/MRCP) findings, a repeated high‐quality MRI/MRCP should be performed for diagnostic purposes. Endoscopic retrograde cholangiopancreatography (ERCP) should be avoided for the diagnosis of PSC (Figure 2). In patients with PSC without known inflammatory bowel disease (IBD), diagnostic colonoscopy with histological sampling should be performed and may be repeated every 5 years if IBD is not initially detected. Colon cancer surveillance should begin at age 15 years in patients with PSC and IBD. New clinical risk tools for PSC are available for risk stratification, but probabilities of events in individual patients should be interpreted with caution (Figure 4 and Table 3). All patients with PSC should be considered for participation in clinical trials; however, ursodeoxycholic acid (13–23 mg/kg/day) can be considered and continued if well tolerated with a meaningful improvement in alkaline phosphatase (γ‐glutamyl transferase in children) and/or symptoms with 12 months of treatment. ERCP with biliary brushings for cytology and fluorescent in situ hybridization analysis should be obtained in all patients with suspected perihilar or distal CCA. There is a new United Network for Organ Sharing policy regarding standardization of Model for End‐Stage Liver Disease exceptions for patients with PSC and recurrent cholangitis. Liver transplantation following neoadjuvant therapy is recommended for patients with perihilar CCA < 3 cm in radial diameter that is unresectable or arising in the setting of PSC and in the absence of intrahepatic or extrahepatic metastasis (Figure 9). TABLE 1 - Definitions in PSC PSC Chronic, cholestatic liver disease likely of autoimmune origin characterized by inflammation and fibrosis of intrahepatic and/or extrahepatic bile ducts, leading to the formation of bile duct strictures, and frequently associated with IBD Small‐duct PSC Less common variant of PSC that is characterized by typical cholestatic and histological features of PSC but with normal bile ducts on cholangiography PSC–AIH overlap Concurrent diagnostic features of PSC and clinical, biochemical, and histological features of AIH Secondary sclerosing cholangitis Biliary strictures due to identifiable causes that can result in secondary biliary cirrhosis IgG4 sclerosing cholangitis Biliary strictures due to elevated IgG4‐positive plasma cells in tissue and serum IgG4 elevation frequently associated with pancreatic involvement Dominant stricture A biliary stricture on ERCP with a diameter of ≤1.5 mm in the common bile duct or of ≤1 mm in the hepatic duct High‐grade stricture A biliary stricture on MRI with cholangiopancreatography with >75% reduction in the common bile duct or hepatic ducts Relevant stricture Any biliary stricture of the common bile duct or hepatic ducts associated with signs or symptoms of obstructive cholestasis and/or bacterial cholangitis INTRODUCTION AND SCOPE OF GUIDANCE Primary sclerosing cholangitis (PSC) is a cholangiopathy characterized by chronic fibroinflammatory damage of the biliary tree and is frequently associated with inflammatory bowel disease (IBD). The majority of patients with PSC have fibrotic biliary strictures on cholangiogram, whereas a minority have small‐duct PSC, characterized by a normal cholangiogram but with histological features of PSC on liver biopsy. A small percentage have overlapping features of autoimmune hepatitis (PSC‐AIH). PSC affects both male and female individuals and can occur at any age. PSC is considered an autoimmune disease, though the pathophysiology remains poorly understood. PSC frequently results in cholestatic liver damage, cirrhosis, and liver failure and can recur in 20%–30% of patients PSC the risk of cholangiocarcinoma (CCA) and cancer is therapy for PSC, and clinical with a of diagnostic for A of new biliary strictures, is in Table for the of Liver guidance a to the diagnosis and management of PSC and CCA. are by of the of the of the and of the if of results the of and In guidance by of an and guidance on and analysis of the on the with by the at all of guidance The to a guidance on a of not available to the of a meaningful In to the of to the 2010 new for the of biliary strictures, an on for diagnosis retrograde cholangiopancreatography (ERCP) and liver of and for clinical and management of OF PSC of PSC have The majority of to have in and of and are and have that the and of PSC may be of the a PSC to the United and the United to be by PSC at to of PSC is the of and with a ag
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., S. Sulkowski, M., Torriani, F. J., Dieterich, D. T., Thomas, D. L., et al. (2006) · Hepatology · doi:10.1002/hep.21178 · Cited by 5,021
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Valle, J., Wasan, H., Palmer, D. H., Cunningham, D., Anthoney, A., Maraveyas, A., Madhusudan, S., Iveson, T., Hughes, S., Pereira, S. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908721 · Cited by 4,406
The 2019 WHO classification of tumours of the digestive system
Nagtegaal, I. D., Odze, R. D., Klimstra, D., Paradis, V., Rugge, M., Schirmacher, P., Washington, K. M., Carneiro, F., Cree, I. A., & the WHO Classification of Tumours Editorial Board (2020) · Histopathology · doi:10.1111/his.13975 · Cited by 4,192
AASLD guidelines for the treatment of hepatocellular carcinoma
Heimbach, J. K., Kulik, L. M., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H., & Marrero, J. A. (2018) · Hepatology · doi:10.1002/hep.29086 · Cited by 4,070
Expanding consensus in portal hypertension
de Franchis, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.022 · Cited by 3,078
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
Self-citationCholangiocarcinoma — evolving concepts and therapeutic strategies
Ilyas, S. I., Khan, S. A., Hallemeier, C. L., Kelley, R. K., & Gores, G. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.157 · Cited by 1,626
Self-citationAbou-Alfa, G. K., Sahai, V., Hollebecque, A., Vaccaro, G., Melisi, D., Al-Rajabi, R., Paulson, A. S., Borad, M. J., Gallinson, D., Murphy, A. G., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30109-1 · Cited by 1,611
ACG Clinical Guideline: Ulcerative Colitis in Adults
Rubin, D. T., Ananthakrishnan, A. N., Siegel, C. A., Sauer, B. G., & Long, M. D. (2019) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000152 · Cited by 1,577
Banales, J. M., Cardinale, V., Carpino, G., Marzioni, M., Andersen, J. B., Invernizzi, P., Lind, G. E., Folseraas, T., Forbes, S. J., Fouassier, L., et al. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.51 · Cited by 1,376
Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma
Jarnagin, W. R., Fong, Y., DeMatteo, R. P., Gonen, M., Burke, E. C., Bodniewicz, J., Youssef, M., Klimstra, D., & Blumgart, L. H. (2001) · Annals of Surgery · doi:10.1097/00000658-200110000-00010 · Cited by 1,347
Primrose, J. N., Fox, R. P., Palmer, D. H., Malik, H. Z., Prasad, R., Mirza, D., Anthony, A., Corrie, P., Falk, S., Finch-Jones, M., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30915-x · Cited by 1,273
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,224
EASL Clinical Practice Guidelines on nutrition in chronic liver disease
Merli, M., Berzigotti, A., Zelber-Sagi, S., Dasarathy, S., Montagnese, S., Genton, L., Plauth, M., & Parés, A. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.024 · Cited by 1,130
Abou-Alfa, G. K., Macarulla, T., Javle, M. M., Kelley, R. K., Lubner, S. J., Adeva, J., Cleary, J. M., Catenacci, D. V., Borad, M. J., Bridgewater, J., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30157-1 · Cited by 1,116
Self-citationMack, C. L., Adams, D., Assis, D. N., Kerkar, N., Manns, M. P., Mayo, M. J., Vierling, J. M., Alsawas, M., Murad, M. H., & Czaja, A. J. (2020) · Hepatology · doi:10.1002/hep.31065 · Cited by 983
Self-citationERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Dumonceau, J.-M., Kapral, C., Aabakken, L., Papanikolaou, I. S., Tringali, A., Vanbiervliet, G., Beyna, T., Dinis-Ribeiro, M., Hritz, I., Mariani, A., et al. (2020) · Endoscopy · doi:10.1055/a-1075-4080 · Cited by 934
Mast cell secretory granules: armed for battle
Wernersson, S., & Pejler, G. (2014) · Nature Reviews Immunology · doi:10.1038/nri3690 · Cited by 906
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy
Ghazale, A., Chari, S. T., Zhang, L., Smyrk, T. C., Takahashi, N., Levy, M. J., Topazian, M. D., Clain, J. E., Pearson, R. K., Petersen, B. T., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.12.009 · Cited by 890
Primary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868
Adverse events associated with ERCP
Chandrasekhara, V., Khashab, M. A., Muthusamy, V. R., Acosta, R. D., Agrawal, D., Bruining, D. H., Eloubeidi, M. A., Fanelli, R. D., Faulx, A. L., Gurudu, S. R., et al. (2017) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2016.06.051 · Cited by 864
Biggins, S. W., Angeli, P., Garcia‐Tsao, G., Ginès, P., Ling, S. C., Nadim, M. K., Wong, F., & Kim, W. R. (2021) · Hepatology · doi:10.1002/hep.31884 · Cited by 846
Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes
Ray, J. G., Vermeulen, M. J., Bharatha, A., Montanera, W. J., & Park, A. L. (2016) · JAMA · doi:10.1001/jama.2016.12126 · Cited by 845
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Broomé, U., Olsson, R., Lööf, L., Bodemar, G., Hultcrantz, R., Danielsson, A., Prytz, H., Sandberg-Gertzén, H., Wallerstedt, S., & Lindberg, G. (1996) · Gut · doi:10.1136/gut.38.4.610 · Cited by 819
The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study
Bernstein, C. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02319-x · Cited by 815
Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
Saha, S. K., Zhu, A. X., Fuchs, C. S., & Brooks, G. A. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0446 · Cited by 786
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
Loftus, E. V., Harewood, G. C., Loftus, C. G., Tremaine, W. J., Harmsen, W. S., Zinsmeister, A. R., Jewell, D. A., & Sandborn, W. J. (2005) · Gut · doi:10.1136/gut.2004.046615 · Cited by 777
Laine, L., Kaltenbach, T., Barkun, A., McQuaid, K. R., Subramanian, V., Soetikno, R., East, J. E., Farraye, F. A., Feagan, B., Ioannidis, J., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.031 · Cited by 776
de Jong, M. C., Nathan, H., Sotiropoulos, G. C., Paul, A., Alexandrescu, S., Marques, H., Pulitano, C., Barroso, E., Clary, B. M., Aldrighetti, L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.6519 · Cited by 729
Boonstra, K., Weersma, R. K., van Erpecum, K. J., Rauws, E. A., Spanier, B. W. M., Poen, A. C., van Nieuwkerk, K. M., Drenth, J. P., Witteman, B. J., Tuynman, H. A., et al. (2013) · Hepatology · doi:10.1002/hep.26565 · Cited by 725
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., Luketic, V. A. C., Harrison, E. M., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., et al. (2009) · Hepatology · doi:10.1002/hep.23082 · Cited by 720
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
Bergquist, A., Ekbom, A., Olsson, R., Kornfeldt, D., Lööf, L., Danielsson, Å., Hultcrantz, R., Lindgren, S., Prytz, H., Sandberg-Gertzén, H., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00288-4 · Cited by 717
Self-citationRea, D. J., Heimbach, J. K., Rosen, C. B., Haddock, M. G., Alberts, S. R., Kremers, W. K., Gores, G. J., & Nagorney, D. M. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000179678.13285.fa · Cited by 693
ESPEN guideline on clinical nutrition in liver disease
Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., & Bischoff, S. C. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.12.022 · Cited by 674
Nagino, M., Ebata, T., Yokoyama, Y., Igami, T., Sugawara, G., Takahashi, Y., & Nimura, Y. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182708b57 · Cited by 656
Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma
Bertuccio, P., Malvezzi, M., Carioli, G., Hashim, D., Boffetta, P., El-Serag, H. B., La Vecchia, C., & Negri, E. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.03.013 · Cited by 648
Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
Wiesner, R. H., Grambsch, P. M., Dickson, R. E., Ludwig, J., Maccarty, R. L., Hunter, E. B., Fleming, T. R., Fisher, L. D., Beaver, S. J., & Larusso, N. F. (1989) · Hepatology · doi:10.1002/hep.1840100406 · Cited by 643
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
Corpechot, C., Chazouillères, O., Rousseau, A., Le Gruyer, A., Habersetzer, F., Mathurin, P., Goria, O., Potier, P., Minello, A., Silvain, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714519 · Cited by 642
Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review
Boonstra, K., Beuers, U., & Ponsioen, C. Y. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.025 · Cited by 632
New Horizons for Precision Medicine in Biliary Tract Cancers
Valle, J. W., Lamarca, A., Goyal, L., Barriuso, J., & Zhu, A. X. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0245 · Cited by 626
Soetikno, R. M., Lin, O. S., Heidenreich, P. A., Young, H. S., & Blackstone, M. O. (2002) · Gastrointestinal Endoscopy · doi:10.1067/mge.2002.125367 · Cited by 623
Ursodiol for Primary Sclerosing Cholangitis
Lindor, K. D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361003 · Cited by 598
Darwish Murad, S., Kim, W. R., Harnois, D. M., Douglas, D. D., Burton, J., Kulik, L. M., Botha, J. F., Mezrich, J. D., Chapman, W. C., Schwartz, J. J., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.008 · Cited by 597
Tse, R. V., Hawkins, M., Lockwood, G., Kim, J. J., Cummings, B., Knox, J., Sherman, M., & Dawson, L. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.3529 · Cited by 589
Hirschfield, G. M., Mason, A., Luketic, V., Lindor, K., Gordon, S. C., Mayo, M., Kowdley, K. V., Vincent, C., Bodhenheimer, H. C., Parés, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.12.005 · Cited by 576
Penna, C., Dozois, R., Tremaine, W., Sandborn, W., LaRusso, N., Schleck, C., & Ilstrup, D. (1996) · Gut · doi:10.1136/gut.38.2.234 · Cited by 561
Antibiotic prophylaxis for GI endoscopy
Banerjee, S., Shen, B., Baron, T. H., Nelson, D. B., Anderson, M. A., Cash, B. D., Dominitz, J. A., Gan, S. I., Harrison, M. E., Ikenberry, S. O., et al. (2008) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2008.02.068 · Cited by 557
Boberg, K. M., Chapman, R. W., Hirschfield, G. M., Lohse, A. W., Manns, M. P., & Schrumpf, E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.002 · Cited by 555
Clements, O., Eliahoo, J., Kim, J. U., Taylor-Robinson, S. D., & Khan, S. A. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.09.007 · Cited by 550
Weismüller, T. J., Trivedi, P. J., Bergquist, A., Imam, M., Lenzen, H., Ponsioen, C. Y., Holm, K., Gotthardt, D., Färkkilä, M. A., Marschall, H.-U., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.038 · Cited by 533
Self-citationSubbiah, V., Lassen, U., Élez, E., Italiano, A., Curigliano, G., Javle, M., de Braud, F., Prager, G. W., Greil, R., Stein, A., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30321-1 · Cited by 533
Cholangiocarcinoma: lessons from Thailand
Sripa, B., & Pairojkul, C. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282fbf9b3 · Cited by 531
ACG clinical guideline: primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., & Harrison, E. M. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.112 · Cited by 524
K. M. BOBERG, E. A. (1998) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529850166284 · Cited by 517
Tumour necrosis factor-α induces ectopic activity in nociceptive primary afferent fibres
Sorkin, L. S., Xiao, W.-H., Wagner, R., & Myers, R. R. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00147-4 · Cited by 503
Adam, R., Karam, V., Cailliez, V., O Grady, J. G., Mirza, D., Cherqui, D., Klempnauer, J., Salizzoni, M., Pratschke, J., Jamieson, N., et al. (2018) · Transplant International · doi:10.1111/tri.13358 · Cited by 498
Piha‐Paul, S. A., Oh, D., Ueno, M., Malka, D., Chung, H. C., Nagrial, A., Kelley, R. K., Ros, W., Italiano, A., Nakagawa, K., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33013 · Cited by 486
Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential
Broomé, U., Löfberg, R., Veress, B., & Eriksson, L. S. (1995) · Hepatology · doi:10.1002/hep.1840220511 · Cited by 481
Hong, T. S., Wo, J. Y., Yeap, B. Y., Ben-Josef, E., McDonnell, E. I., Blaszkowsky, L. S., Kwak, E. L., Allen, J. N., Clark, J. W., Goyal, L., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.2710 · Cited by 472
Natural history and prognostic variables in primary sclerosing cholangitis
Farrant, J. M., Hayllar, K. M., Wilkinson, M. L., Karani, J., Portmann, B. C., Westaby, D., & Williams, R. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90673-9 · Cited by 468
Shroff, R. T., Javle, M. M., Xiao, L., Kaseb, A. O., Varadhachary, G. R., Wolff, R. A., Raghav, K. P. S., Iwasaki, M., Masci, P., Ramanathan, R. K., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0270 · Cited by 468
Self-citationBambha, K., Kim, W. R., Talwalkar, J., Torgerson, H., Benson, J. T., Therneau, T. M., Loftus, E. V., Yawn, B. P., Dickson, E. R., & Melton, L. J. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.07.011 · Cited by 450
Kim, R. D., Chung, V., Alese, O. B., El-Rayes, B. F., Li, D., Al-Toubah, T. E., Schell, M. J., Zhou, J.-M., Mahipal, A., Kim, B. H., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.0930 · Cited by 450
Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline
Shroff, R. T., Kennedy, E. B., Bachini, M., Bekaii-Saab, T., Crane, C., Edeline, J., El-Khoueiry, A., Feng, M., Katz, M. H. G., Primrose, J., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02178 · Cited by 445
Self-citationA Revised Natural History Model for Primary Sclerosing Cholangitis
KIM, W. R., THERNEAU, T. M., WIESNER, R. H., POTERUCHA, J. J., BENSON, J. T., MALINCHOC, M., LARUSSO, N. F., LINDOR, K. D., & DICKSON, E. R. (2000) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)64614-4 · Cited by 434
Prevalence of Primary Sclerosing Cholangitis in Patients With Ulcerative Colitis
Olsson, R., Danielsson, Å., Järnerot, G., Lindström, E., Lööf, L., Rolny, P., Rydén, B.-O., Tysk, C., & Wallerstedt, S. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)70019-t · Cited by 426
Kummen, M., Holm, K., Anmarkrud, J. A., Nygård, S., Vesterhus, M., Høivik, M. L., Trøseid, M., Marschall, H.-U., Schrumpf, E., Moum, B., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310500 · Cited by 426
Nakamoto, N., Sasaki, N., Aoki, R., Miyamoto, K., Suda, W., Teratani, T., Suzuki, T., Koda, Y., Chu, P.-S., Taniki, N., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0333-1 · Cited by 425
Patel, A. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00744-3 · Cited by 425
Biliary cancer: Utility of next‐generation sequencing for clinical management
Javle, M., Bekaii‐Saab, T., Jain, A., Wang, Y., Kelley, R. K., Wang, K., Kang, H. C., Catenacci, D., Ali, S., Krishnan, S., et al. (2016) · Cancer · doi:10.1002/cncr.30254 · Cited by 418
Self-citationLaine, L., Kaltenbach, T., Barkun, A., McQuaid, K. R., Subramanian, V., Soetikno, R., East, J. E., Farraye, F. A., Feagan, B., Ioannidis, J., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.12.009 · Cited by 415
Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD
Sabino, J., Vieira-Silva, S., Machiels, K., Joossens, M., Falony, G., Ballet, V., Ferrante, M., Van Assche, G., Van der Merwe, S., Vermeire, S., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-311004 · Cited by 413
Tischendorf, J. J. W., Hecker, H., Krüger, M., Manns, M. P., & Meier, P. N. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00872.x · Cited by 413
De Vreede, I., Steers, J. L., Burch, P. A., Rosen, C. B., Gunderson, L. L., Haddock, M. G., Burgart, L., & Gores, G. J. (2000) · Liver Transplantation · doi:10.1053/lv.2000.6143 · Cited by 395
Olsson, R., Boberg, K. M., Schaffalitsky de Muckadell, O., Lindgren, S., Hultcrantz, R., Folvik, G., Bell, H., Gangsøy–Kristiansen, M., Matre, J., Rydning, A., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.08.017 · Cited by 394
Charatcharoenwitthaya, P., Enders, F. B., Halling, K. C., & Lindor, K. D. (2008) · Hepatology · doi:10.1002/hep.22441 · Cited by 393
The UK-PSCSC Consortium, Liu, J. Z., The International IBD Genetics Consortium, The International PSC Study Group, Hov, J. R., Folseraas, T., Ellinghaus, E., Rushbrook, S. M., Doncheva, N. T., Andreassen, O. A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2616 · Cited by 391
Self-citationAntibiotic prophylaxis for GI endoscopy
Khashab, M. A., Chithadi, K. V., Acosta, R. D., Bruining, D. H., Chandrasekhara, V., Eloubeidi, M. A., Fanelli, R. D., Faulx, A. L., Fonkalsrud, L., Lightdale, J. R., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.08.008 · Cited by 386
The TGR5 receptor mediates bile acid–induced itch and analgesia
Alemi, F., Kwon, E., Poole, D. P., Lieu, T., Lyo, V., Cattaruzza, F., Cevikbas, F., Steinhoff, M., Nassini, R., Materazzi, S., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64551 · Cited by 378
Recurrence of Primary Sclerosing Cholangitis Following Liver Transplantation
Graziadei, I. W., Wiesner, R. H., Batts, K. P., Marotta, P. J., LaRusso, N. F., Porayko, M. K., Hay, E. J., Gores, G. J., Charlton, M. R., Ludwig, J., et al. (1999) · Hepatology · doi:10.1002/hep.510290427 · Cited by 375
Sapisochin, G., Facciuto, M., Rubbia‐Brandt, L., Marti, J., Mehta, N., Yao, F. Y., Vibert, E., Cherqui, D., Grant, D. R., Hernandez‐Alejandro, R., et al. (2016) · Hepatology · doi:10.1002/hep.28744 · Cited by 370
Self-citationGenome-Wide Association Analysis in Primary Sclerosing Cholangitis
Karlsen, T. H., Franke, A., Melum, E., Kaser, A., Hov, J. R., Balschun, T., Lie, B. A., Bergquist, A., Schramm, C., Weismüller, T. J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.11.046 · Cited by 361
Self-citationEksteen, B., Grant, A. J., Miles, A., Curbishley, S. M., Lalor, P. F., Hübscher, S. G., Briskin, M., Salmon, M., & Adams, D. H. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041035 · Cited by 360
Bajer, L., Kverka, M., Kostovcik, M., Macinga, P., Dvorak, J., Stehlikova, Z., Brezina, J., Wohl, P., Spicak, J., & Drastich, P. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i25.4548 · Cited by 360
The UK-PSC Consortium, Ji, S.-G., The International IBD Genetics Consortium, The International PSC Study Group, Juran, B. D., Mucha, S., Folseraas, T., Jostins, L., Melum, E., Kumasaka, N., et al. (2017) · Nature Genetics · doi:10.1038/ng.3745 · Cited by 357
Self-citationA preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis
Mitchell, S. A., Bansi, D. S., Hunt, N., Bergmann, K. V., Fleming, K. A., & Chapman, R. W. (2001) · Gastroenterology · doi:10.1053/gast.2001.27965 · Cited by 351
American Gastroenterological Association
(1958) · The Lancet · doi:10.1016/s0140-6736(58)92067-1 · Cited by 350
Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study
Wolfhagen, F., Sternieri, E., Hop, W., Vitale, G., Bertolotti, M., & Van Buuren, H. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9322521 · Cited by 343
Cheung, K., Lee, S. S., & Raman, M. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.016 · Cited by 343
Levy, C., Lymp, J., Angulo, P., Gores, G. J., Larusso, N., & Lindor, K. D. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2927-8 · Cited by 339
Second-line chemotherapy in advanced biliary cancer: a systematic review
Lamarca, A., Hubner, R. A., David Ryder, W., & Valle, J. W. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu162 · Cited by 339
Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study
Chalasani, N., Baluyut, A., Ismail, A., Zaman, A., Sood, G., Ghalib, R., McCashland, T. M., Reddy, R. K., Zervos, X., Anbari, M. A., et al. (2000) · Hepatology · doi:10.1002/hep.510310103 · Cited by 336
Ludwig, J., Barham, S. S., Larusso, N. F., Elveback, L. R., Wiesner, R. H., & McCall, J. T. (1981) · Hepatology · doi:10.1002/hep.1840010612 · Cited by 328
Goss, J. A., Shackleton, C. R., Farmer, D. G., Arnaout, W. S., Seu, P., Markowitz, J. S., Martin, P., Stribling, R. J., Goldstein, L. I., & Busuttil, R. W. (1997) · Annals of Surgery · doi:10.1097/00000658-199705000-00004 · Cited by 328
Sudan, D., DeRoover, A., Chinnakotla, S., Fox, I., Shaw, B., McCashland, T., Sorrell, M., Tempero, M., & Langnas, A. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.20812.x · Cited by 314
Fickert, P., Zollner, G., Fuchsbichler, A., Stumptner, C., Weiglein, A. H., Lammert, F., Marschall, H., Tsybrovskyy, O., Zatloukal, K., Denk, H., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.35948 · Cited by 313
Tao, R., Krishnan, S., Bhosale, P. R., Javle, M. M., Aloia, T. A., Shroff, R. T., Kaseb, A. O., Bishop, A. J., Swanick, C. W., Koay, E. J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.3778 · Cited by 309
Self-citationLakatos, L. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i10.2300 · Cited by 308
The natural history of small-duct primary sclerosing cholangitis
Björnsson, E., Olsson, R., Bergquist, A., Lindgren, S., Braden, B., Chapman, R. W., Boberg, K. M., & Angulo, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.042 · Cited by 305
Self-citationPetrowsky, H., Wildbrett, P., Husarik, D. B., Hany, T. F., Tam, S., Jochum, W., & Clavien, P.-A. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.03.009 · Cited by 305
Corpechot, C., Gaouar, F., El Naggar, A., Kemgang, A., Wendum, D., Poupon, R., Carrat, F., & Chazouillères, O. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.030 · Cited by 300
Alabraba, E., Nightingale, P., Gunson, B., Hubscher, S., Olliff, S., Mirza, D., & Neuberger, J. (2009) · Liver Transplantation · doi:10.1002/lt.21679 · Cited by 298
Lunsford, K. E., Javle, M., Heyne, K., Shroff, R. T., Abdel-Wahab, R., Gupta, N., Mobley, C. M., Saharia, A., Victor, D. W., Nguyen, D. T., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30045-1 · Cited by 298
Self-citationnorUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
Fickert, P., Hirschfield, G. M., Denk, G., Marschall, H.-U., Altorjay, I., Färkkilä, M., Schramm, C., Spengler, U., Chapman, R., Bergquist, A., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.009 · Cited by 297
Stiehl, A., Rudolph, G., Klöters-Plachky, P., Sauer, P., & Walker, S. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00251-3 · Cited by 293
Cancer surveillance in patients with primary sclerosing cholangitis
Razumilava, N., Gores, G. J., & Lindor, K. D. (2011) · Hepatology · doi:10.1002/hep.24570 · Cited by 292
Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?
Khan, S. A., Emadossadaty, S., Ladep, N. G., Thomas, H. C., Elliott, P., Taylor-Robinson, S. D., & Toledano, M. B. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.11.015 · Cited by 290
Heimbach, J. K., Sanchez, W., Rosen, C. B., & Gores, G. J. (2011) · HPB · doi:10.1111/j.1477-2574.2011.00298.x · Cited by 288
Bergquist, A., Glaumann, H., Persson, B., & Broomé, U. (1998) · Hepatology · doi:10.1002/hep.510270201 · Cited by 281
Self-citationLiver Transplantation for Unresectable Perihilar Cholangiocarcinoma
Heimbach, J., Gores, G., Haddock, M., Alberts, S., Nyberg, S., Ishitani, M., & Rosen, C. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828896 · Cited by 275
Nuzzo, G. (2012) · Archives of Surgery · doi:10.1001/archsurg.2011.771 · Cited by 275
Kaplan, G. G., Laupland, K. B., Butzner, D., Urbanski, S. J., & Lee, S. S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01103.x · Cited by 273
Incidence of primary sclerosing cholangitis: A systematic review and meta-analysis
Molodecky, N. A., Kareemi, H., Parab, R., Barkema, H. W., Quan, H., Myers, R. P., & Kaplan, G. G. (2011) · Hepatology · doi:10.1002/hep.24247 · Cited by 273
Popov, Y., Patsenker, E., Fickert, P., Trauner, M., & Schuppan, D. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.025 · Cited by 268
Eaton, J. E., Silveira, M. G., Pardi, D. S., Sinakos, E., Kowdley, K. V., Luketic, V. A. C., Harrison, E. M., McCashland, T., Befeler, A. S., Harnois, D., et al. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.156 · Cited by 268
Ponsioen, C. Y., Vrouenraets, S. M. E., Prawirodirdjo, W., Rajaram, R., Rauws, E. A. J., Mulder, C. J. J., Reitsma, J. B., Heisterkamp, S. H., & Tytgat, G. N. J. (2002) · Gut · doi:10.1136/gut.51.4.562 · Cited by 268
Tabibian, J. H., Weeding, E., Jorgensen, R. A., Petz, J. L., Keach, J. C., Talwalkar, J. A., & Lindor, K. D. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12232 · Cited by 267
Self-citationDave, M., Elmunzer, B. J., Dwamena, B. A., & Higgins, P. D. R. (2010) · Radiology · doi:10.1148/radiol.10091953 · Cited by 265
Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma
Farges, O., Regimbeau, J. M., Fuks, D., Le Treut, Y. P., Cherqui, D., Bachellier, P., Mabrut, J. Y., Adham, M., Pruvot, F. R., & Gigot, J. F. (2013) · Journal of British Surgery · doi:10.1002/bjs.8950 · Cited by 263
Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease
Boonstra, K., van Erpecum, K. J., van Nieuwkerk, K. M. J., Drenth, J. P. H., Poen, A. C., Witteman, B. J. M., Tuynman, H. A. R. E., Beuers, U., & Ponsioen, C. Y. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22938 · Cited by 262
Trauner, M., Gulamhusein, A., Hameed, B., Caldwell, S., Shiffman, M. L., Landis, C., Eksteen, B., Agarwal, K., Muir, A., Rushbrook, S., et al. (2019) · Hepatology · doi:10.1002/hep.30509 · Cited by 261
Self-citationSurgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience
Lee, S. G., Song, G. W., Hwang, S., Ha, T. Y., Moon, D. B., Jung, D. H., Kim, K. H., Ahn, C. S., Kim, M. H., Lee, S. K., et al. (2010) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1007/s00534-009-0204-5 · Cited by 259
Treatment of pruritus in primary biliary cirrhosis with rifampin
Ghent, C. N., & Carruthers, S. G. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90442-8 · Cited by 257
Melum, E., Franke, A., Schramm, C., Weismüller, T. J., Gotthardt, D. N., Offner, F. A., Juran, B. D., Laerdahl, J. K., Labi, V., Björnsson, E., et al. (2011) · Nature Genetics · doi:10.1038/ng.728 · Cited by 256
Self-citationNeoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma
Le Roy, B., Gelli, M., Pittau, G., Allard, M. A., Pereira, B., Serji, B., Vibert, E., Castaing, D., Adam, R., Cherqui, D., et al. (2018) · Journal of British Surgery · doi:10.1002/bjs.10641 · Cited by 256
Aabakken, L., Karlsen, T., Albert, J., Arvanitakis, M., Chazouilleres, O., Dumonceau, J.-M., Färkkilä, M., Fickert, P., Hirschfield, G., Laghi, A., et al. (2017) · Endoscopy · doi:10.1055/s-0043-107029 · Cited by 255
Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent
Zhang, X. F., Beal, E. W., Bagante, F., Chakedis, J., Weiss, M., Popescu, I., Marques, H. P., Aldrighetti, L., Maithel, S. K., Pulitano, C., et al. (2018) · Journal of British Surgery · doi:10.1002/bjs.10676 · Cited by 250
The Risk for Cancer Or Dysplasia in Ulcerative Colitis Patients With Primary Sclerosing Cholangitis
Shetty, K., Rybicki, L. A., Brzezinski, A., Carey, W. D., & Lashner, B. A. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00212-9 · Cited by 245
High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis
Harnois, D. M., Angulo, P., Jorgensen, R. A., LaRusso, N. F., & Lindor, K. D. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03777.x · Cited by 242
Wijnands, A. M., de Jong, M. E., Lutgens, M. W. M. D., Hoentjen, F., Elias, S. G., & Oldenburg, B. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.036 · Cited by 240
Role of EUS for preoperative evaluation of cholangiocarcinoma: a large single-center experience
Mohamadnejad, M., DeWitt, J. M., Sherman, S., LeBlanc, J. K., Pitt, H. A., House, M. G., Jones, K. J., Fogel, E. L., McHenry, L., Watkins, J. L., et al. (2011) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2010.08.050 · Cited by 239
Deneau, M., Jensen, K. M., Holmen, J., Williams, M. S., Book, L. S., & Guthery, S. L. (2013) · Hepatology · doi:10.1002/hep.26454 · Cited by 233
Self-citationAGA technical review on osteoporosis in hepatic disorders
LESLIE, W. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01062-x · Cited by 232
Folseraas, T., Melum, E., Rausch, P., Juran, B. D., Ellinghaus, E., Shiryaev, A., Laerdahl, J. K., Ellinghaus, D., Schramm, C., Weismüller, T. J., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.03.031 · Cited by 232
Self-citationRisk factors for recurrence of primary sclerosing cholangitis of liver allograft
Vera, A., Moledina, S., Gunson, B., Hubscher, S., Mirza, D., Olliff, S., & Neuberger, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11861-7 · Cited by 231
Deneau, M. R., El‐Matary, W., Valentino, P. L., Abdou, R., Alqoaer, K., Amin, M., Amir, A. Z., Auth, M., Bazerbachi, F., Broderick, A., et al. (2017) · Hepatology · doi:10.1002/hep.29204 · Cited by 230
Self-citationClinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome
Floreani, A., Rizzotto, E. R., Ferrara, F., Carderi, I., Caroli, D., Blasone, L., & Baldo, V. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41841.x · Cited by 230
Cercek, A., Boerner, T., Tan, B. R., Chou, J. F., Gönen, M., Boucher, T. M., Hauser, H. F., Do, R. K. G., Lowery, M. A., Harding, J. J., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2019.3718 · Cited by 228
Pruritus in cholestasis: facts and fiction
Beuers, U., Kremer, A. E., Bolier, R., & Elferink, R. P. J. O. (2014) · Hepatology · doi:10.1002/hep.26909 · Cited by 225
de Vries, E., Bolier, R., Goet, J., Parés, A., Verbeek, J., de Vree, M., Drenth, J., van Erpecum, K., van Nieuwkerk, K., van der Heide, F., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.10.001 · Cited by 224
Hoffmann, R.-T., Paprottka, P. M., Schön, A., Bamberg, F., Haug, A., Dürr, E.-M., Rauch, B., Trumm, C. T., Jakobs, T. F., Helmberger, T. K., et al. (2012) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-011-0142-x · Cited by 224
Tabibian, J. H., O'Hara, S. P., Trussoni, C. E., Tietz, P. S., Splinter, P. L., Mounajjed, T., Hagey, L. R., & LaRusso, N. F. (2016) · Hepatology · doi:10.1002/hep.27927 · Cited by 223
Self-citationColorectal cancer in Crohn's disease: a Scandinavian population-based cohort study
Olén, O., Erichsen, R., Sachs, M. C., Pedersen, L., Halfvarson, J., Askling, J., Ekbom, A., Sørensen, H. T., & Ludvigsson, J. F. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30005-4 · Cited by 223
Poupon, R. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/s2210-7401(12)70015-3 · Cited by 222
Färkkilä, M., Karvonen, A., Nurmi, H., Nuutinen, H., Taavitsainen, M., Pikkarainen, P., & Kärkkäinen, P. (2004) · Hepatology · doi:10.1002/hep.20457 · Cited by 218
Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection
Koerkamp, B. G., Wiggers, J. K., Allen, P. J., Besselink, M. G., Blumgart, L. H., Busch, O. R. C., Coelen, R. J., D’Angelica, M. I., DeMatteo, R. P., Gouma, D. J., et al. (2015) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2015.09.005 · Cited by 218
Hepatitis B Virus Infection and Intrahepatic Cholangiocarcinoma in Korea: A Case-Control Study
Lee, T. Y., Lee, S. S., Jung, S. W., Jeon, S. H., Yun, S.-C., Oh, H.-C., Kwon, S., Lee, S. K., Seo, D. W., Kim, M.-H., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01796.x · Cited by 217
Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis
Lemoinne, S., Kemgang, A., Ben Belkacem, K., Straube, M., Jegou, S., Corpechot, C., Saint-Antoine IBD Network, Chazouillères, O., Housset, C., & Sokol, H. (2020) · Gut · doi:10.1136/gutjnl-2018-317791 · Cited by 215
Surgical Management of Intrahepatic Cholangiocarcinoma - A Population-Based Study
Tan, J. C. C., Coburn, N. G., Baxter, N. N., Kiss, A., & Law, C. H. L. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9627-x · Cited by 213
Lunder, A. K., Hov, J. R., Borthne, A., Gleditsch, J., Johannesen, G., Tveit, K., Viktil, E., Henriksen, M., Hovde, Ø., Huppertz-Hauss, G., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.021 · Cited by 212
Petrick, J. L., Yang, B., Altekruse, S. F., Van Dyke, A. L., Koshiol, J., Graubard, B. I., & McGlynn, K. A. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186643 · Cited by 210
Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in sweden†
Lindkvist, B., Benito de Valle, M., Gullberg, B., & Björnsson, E. (2010) · Hepatology · doi:10.1002/hep.23678 · Cited by 206
Al Mamari, S., Djordjevic, J., Halliday, J. S., & Chapman, R. W. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.013 · Cited by 204
Chapman, M. H., Webster, G. J. M., Bannoo, S., Johnson, G. J., Wittmann, J., & Pereira, S. P. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283554bbf · Cited by 204
Trikudanathan, G., Navaneethan, U., Njei, B., Vargo, J. J., & Parsi, M. A. (2014) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2013.09.015 · Cited by 203
Coelen, R. J. S., Roos, E., Wiggers, J. K., Besselink, M. G., Buis, C. I., Busch, O. R. C., Dejong, C. H. C., van Delden, O. M., van Eijck, C. H. J., Fockens, P., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30234-6 · Cited by 203
Watanabe, T., Ajioka, Y., Mitsuyama, K., Watanabe, K., Hanai, H., Nakase, H., Kunisaki, R., Matsuda, K., Iwakiri, R., Hida, N., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.002 · Cited by 200
Rowe, I. A., Webb, K., Gunson, B. K., Mehta, N., Haque, S., & Neuberger, J. (2008) · Transplant International · doi:10.1111/j.1432-2277.2007.00628.x · Cited by 199
Muir, A. J., Levy, C., Janssen, H. L. A., Montano‐Loza, A. J., Shiffman, M. L., Caldwell, S., Luketic, V., Ding, D., Jia, C., McColgan, B. J., et al. (2019) · Hepatology · doi:10.1002/hep.30237 · Cited by 195
Ellinghaus, D., Folseraas, T., Holm, K., Ellinghaus, E., Melum, E., Balschun, T., Laerdahl, J. K., Shiryaev, A., Gotthardt, D. N., Weismüller, T. J., et al. (2013) · Hepatology · doi:10.1002/hep.25977 · Cited by 194
Self-citationGallbladder disease in patients with primary sclerosing cholangitis
Said, K., Glaumann, H., & Bergquist, A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.019 · Cited by 193
Self-citationQuality of life before and after liver transplantation for cholestatic liver disease
Gross, C. R., Malinchoc, M., Kim, R. W., Evans, R. W., Wiesner, R. H., Petz, J. L., Crippin, J. S., Klintmalm, G. B., Levy, M. F., Ricci, P., et al. (1999) · Hepatology · doi:10.1002/hep.510290229 · Cited by 192
Kowdley, K. V., Vuppalanchi, R., Levy, C., Floreani, A., Andreone, P., LaRusso, N. F., Shrestha, R., Trotter, J., Goldberg, D., Rushbrook, S., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.033 · Cited by 192
Self-citationJones, D., Boudes, P. F., Swain, M. G., Bowlus, C. L., Galambos, M. R., Bacon, B. R., Doerffel, Y., Gitlin, N., Gordon, S. C., Odin, J. A., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30246-7 · Cited by 191
Self-citationBoonstra, K., Culver, E. L., de Buy Wenniger, L. M., van Heerde, M. J., van Erpecum, K. J., Poen, A. C., van Nieuwkerk, K. M. J., Spanier, M. B. W., Witteman, B. J. M., Tuynman, H. A. R. E., et al. (2014) · Hepatology · doi:10.1002/hep.26977 · Cited by 190
Papatheodoridis, G. V., Hamilton, M., Mistry, P. K., Davidson, B., Rolles, K., & Burroughs, A. K. (1998) · Gut · doi:10.1136/gut.43.5.639 · Cited by 189
Bergquist, A., Montgomery, S. M., Bahmanyar, S., Olsson, R., Danielsson, Å., Lindgren, S., Prytz, H., Hultcrantz, R., Lööf, L., Sandberg–Gertzén, H., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.03.016 · Cited by 188
Self-citationIbrahim, S. M., Mulcahy, M. F., Lewandowski, R. J., Sato, K. T., Ryu, R. K., Masterson, E. J., Newman, S. B., Benson, A., Omary, R. A., & Salem, R. (2008) · Cancer · doi:10.1002/cncr.23818 · Cited by 188
Autoantibodies in primary sclerosing cholangitis
Hov, J. R., Boberg, K. M., & Karlsen, T. H. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3781 · Cited by 187
Lewis, J. T., Talwalkar, J. A., Rosen, C. B., Smyrk, T. C., & Abraham, S. C. (2007) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213435.99492.8a · Cited by 187
Vera, A., Gunson, B. K., Ussatoff, V., Nightingale, P., Candinas, D., Radley, S., David Mayer, A., Buckels, J. A. C., McMaster, P., Neuberger, J., et al. (2003) · Transplantation · doi:10.1097/01.tp.0000058744.34965.38 · Cited by 187
Sarkar, M., Brady, C. W., Fleckenstein, J., Forde, K. A., Khungar, V., Molleston, J. P., Afshar, Y., & Terrault, N. A. (2021) · Hepatology · doi:10.1002/hep.31559 · Cited by 186
Sapisochin, G., de Lope, C. R., Gastaca, M., de Urbina, J. O., López-Andujar, R., Palacios, F., Ramos, E., Fabregat, J., Castroagudín, J. F., Varo, E., et al. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000494 · Cited by 185
Self-citationTrivedi, P. J., Crothers, H., Mytton, J., Bosch, S., Iqbal, T., Ferguson, J., & Hirschfield, G. M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.049 · Cited by 183
Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice
Guicciardi, M. E., Trussoni, C. E., Krishnan, A., Bronk, S. F., Lorenzo Pisarello, M. J., O'Hara, S. P., Splinter, P. L., Gao, Y., Vig, P., Revzin, A., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.018 · Cited by 183
Verdonk, R. C., Dijkstra, G., Haagsma, E. B., Shostrom, V. K., Van den Berg, A. P., Kleibeuker, J. H., Langnas, A. N., & Sudan, D. L. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01333.x · Cited by 182
Dominant Strictures in Patients with Primary Sclerosing Cholangitis
Björnsson, E., Lindqvist-Ottosson, J., Asztely, M., & Olsson, R. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04106.x · Cited by 180
Lindström, L., Hultcrantz, R., Boberg, K. M., Friis–Liby, I., & Bergquist, A. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.032 · Cited by 180
Self-citationThe gut-adherent microbiota of PSC–IBD is distinct to that of IBD
Quraishi, M. N., Sergeant, M., Kay, G., Iqbal, T., Chan, J., Constantinidou, C., Trivedi, P., Ferguson, J., Adams, D. H., Pallen, M., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-311915 · Cited by 179
Katt, J., Schwinge, D., Schoknecht, T., Quaas, A., Sobottka, I., Burandt, E., Becker, C., Neurath, M. F., Lohse, A. W., Herkel, J., et al. (2013) · Hepatology · doi:10.1002/hep.26447 · Cited by 178
Davies, Y. K., Cox, K. M., Abdullah, B. A., Safta, A., Terry, A. B., & Cox, K. L. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31816fee95 · Cited by 176
Recurrence and rejection in liver transplantation for primary sclerosing cholangitis
Fosby, B. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i1.1 · Cited by 175
Clinically recurrent primary sclerosing cholangitis following liver transplantation: A time course
Campsen, J., Zimmerman, M. A., Trotter, J. F., Wachs, M., Bak, T., Steinberg, T., & Kam, I. (2008) · Liver Transplantation · doi:10.1002/lt.21313 · Cited by 175
Risk factors for recurrent primary sclerosing cholangitis after liver transplantation
Ravikumar, R., Tsochatzis, E., Jose, S., Allison, M., Athale, A., Creamer, F., Gunson, B., Iyer, V., Madanur, M., Manas, D., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.005 · Cited by 173
Bangarulingam, S. Y., Bjornsson, E., Enders, F., Barr Fritcher, E. G., Gores, G., Halling, K. C., & Lindor, K. D. (2010) · Hepatology · doi:10.1002/hep.23277 · Cited by 173
Prospective trial of penicillamine in primary sclerosing cholangitis
LaRusso, N. F., Wiesner, R. H., Ludwig, J., MacCarty, R. L., Beaver, S. J., & Zinsmeister, A. R. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90180-1 · Cited by 172
Knox, T. A., & Kaplan, M. M. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90610-6 · Cited by 171
Role of liver transplantation in the treatment of unresectable liver cancer
Pichlmayr, R., Weimann, A., Oldhafer, K. J., Schlitt, H. J., Klempnauer, J., Bornscheuer, A., Chavan, A., Schmoll, E., Lang, H., Tusch, G., et al. (1995) · World Journal of Surgery · doi:10.1007/bf00299775 · Cited by 166
Is There A Role for Liver Biopsy in Primary Sclerosing Cholangitis?
Burak, K. W., Angulo, P., & Lindor, K. D. (2003) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07401.x · Cited by 165
Eaton, J. E., Vesterhus, M. N., McCauley, B. M., Atkinson, E. J., Schlicht, E. M., Juran, B. D., Gossard, A. A., LaRusso, N. F., Gores, G. J., Karlsen, T. H., et al. (2018) · Hepatology · doi:10.1002/hep.30085 · Cited by 162
Stanich, P. P., Björnsson, E., Gossard, A. A., Enders, F., Jorgensen, R., & Lindor, K. D. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.12.008 · Cited by 161
Kiefer, M. V., Albert, M., McNally, M., Robertson, M., Sun, W., Fraker, D., Olthoff, K., Christians, K., Pappas, S., Rilling, W., et al. (2011) · Cancer · doi:10.1002/cncr.25625 · Cited by 160
Wildner, D., Bernatik, T., Greis, C., Seitz, K., Neurath, M., & Strobel, D. (2015) · Ultraschall in der Medizin - European Journal of Ultrasound · doi:10.1055/s-0034-1399147 · Cited by 160
Lundqvist, K., & Broomé, U. (1997) · Diseases of the Colon & Rectum · doi:10.1007/bf02258391 · Cited by 159
Is liver transplantation indicated for cholangiocarcinoma?
Goldstein, R. M., Stone, M., Tillery, G. W., Senzer, N., Levy, M., Husberg, B. S., Gonwa, T., & Klintmalm, G. (1993) · The American Journal of Surgery · doi:10.1016/s0002-9610(05)80696-8 · Cited by 159
Intra-arterial Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis
Hyder, O. N., Marsh, J. W., Salem, R., Petre, E. N., Kalva, S. P., Liapi, E. A., Cosgrove, D., Neal, D., Kamel, I. R., Zhu, A. X., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3127-y · Cited by 159
Zheng, H.-H., & Jiang, X.-L. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000576 · Cited by 159
Meixiong, J., Vasavda, C., Snyder, S. H., & Dong, X. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1903316116 · Cited by 159
Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic Relevance
Sebode, M., Weiler-Normann, C., Liwinski, T., & Schramm, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00609 · Cited by 158
Rudolph, G., Gotthardt, D., Klöters-Plachky, P., Kulaksiz, H., Rost, D., & Stiehl, A. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.023 · Cited by 156
Cited by
Sex differences in chronic liver disease and benign liver lesions
Cooper, K. M., Delk, M., Devuni, D., & Sarkar, M. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100870 · Cited by 38
Immunobiology of primary sclerosing cholangitis
Cornillet, M., Geanon, D., Bergquist, A., & Björkström, N. K. (2025) · Hepatology · doi:10.1097/hep.0000000000001080 · Cited by 20
Self-citation
Metadata
- Authors
- Bowlus, C. L., Arrivé, L., Bergquist, A., Deneau, M., Forman, L., Ilyas, S. I., Lunsford, K. E., Martinez, M., Sapisochin, G., Shroff, R., Tabibian, J. H., & Assis, D. N.
- Venue
- Hepatology
- Published
- 2022-10-20
- Volume
- 77
- Issue
- 2
- Pages
- 659-702
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W4295048810
- Cited by
- 428
- References
- 473
- FWCI
- 33.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.